Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · Real-Time Price · USD
0.131
+0.005 (3.97%)
Nov 20, 2024, 4:00 PM EST - Market closed
Zomedica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 26.73 | 25.19 | 18.93 | 4.13 | - | - | Upgrade
|
| Revenue Growth (YoY) | 11.33% | 33.05% | 358.02% | - | - | - | Upgrade
|
| Cost of Revenue | 8.12 | 7.87 | 5.46 | 1.08 | - | - | Upgrade
|
| Gross Profit | 18.61 | 17.32 | 13.47 | 3.05 | - | - | Upgrade
|
| Selling, General & Admin | 48.65 | 43.17 | 32.81 | 22.85 | 8.8 | 8.65 | Upgrade
|
| Research & Development | 8.22 | 5.74 | 2.58 | 1.58 | 7.96 | 10.35 | Upgrade
|
| Operating Expenses | 56.87 | 48.91 | 35.39 | 24.43 | 16.76 | 19.78 | Upgrade
|
| Operating Income | -38.26 | -31.59 | -21.92 | -21.37 | -16.76 | -19.78 | Upgrade
|
| Interest Expense | - | -0.18 | -0 | -0.01 | -0 | -0.02 | Upgrade
|
| Interest & Investment Income | 4.26 | 5.46 | 2.7 | 0.36 | 0.03 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.11 | 0.03 | -0.15 | -0.03 | -0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.09 | -0.09 | -0.01 | 0.05 | 0.01 | - | Upgrade
|
| EBT Excluding Unusual Items | -34.2 | -26.38 | -19.38 | -21 | -16.73 | -19.8 | Upgrade
|
| Impairment of Goodwill | -28.22 | -12.2 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 2.17 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.16 | 0.02 | 0 | -0.25 | -0.18 | -0 | Upgrade
|
| Asset Writedown | 0.51 | 0.51 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.53 | - | 0.02 | Upgrade
|
| Pretax Income | -62.07 | -35.86 | -19.38 | -20.72 | -16.91 | -19.78 | Upgrade
|
| Income Tax Expense | 0.12 | -1.33 | -2.37 | -2.33 | - | - | Upgrade
|
| Net Income | -62.19 | -34.53 | -17.02 | -18.38 | -16.91 | -19.78 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 32.04 | - | - | Upgrade
|
| Net Income to Common | -62.19 | -34.53 | -17.02 | -50.42 | -16.91 | -19.78 | Upgrade
|
| Shares Outstanding (Basic) | 980 | 980 | 980 | 957 | 364 | 106 | Upgrade
|
| Shares Outstanding (Diluted) | 980 | 980 | 980 | 957 | 364 | 106 | Upgrade
|
| Shares Change (YoY) | - | - | 2.45% | 162.46% | 242.85% | 13.76% | Upgrade
|
| EPS (Basic) | -0.06 | -0.04 | -0.02 | -0.05 | -0.05 | -0.19 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.04 | -0.02 | -0.05 | -0.05 | -0.19 | Upgrade
|
| Free Cash Flow | -30.79 | -27.31 | -14.22 | -14.42 | -16.25 | -15.79 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.01 | -0.02 | -0.04 | -0.15 | Upgrade
|
| Gross Margin | 69.64% | 68.76% | 71.15% | 73.89% | - | - | Upgrade
|
| Operating Margin | -143.14% | -125.43% | -115.81% | -517.15% | - | - | Upgrade
|
| Profit Margin | -232.70% | -137.10% | -89.88% | -1220.01% | - | - | Upgrade
|
| Free Cash Flow Margin | -115.21% | -108.45% | -75.12% | -348.97% | - | - | Upgrade
|
| EBITDA | -30.45 | -25.29 | -17.88 | -20.24 | -16.23 | -19.51 | Upgrade
|
| EBITDA Margin | -113.94% | -100.43% | -94.46% | - | - | - | Upgrade
|
| D&A For EBITDA | 7.81 | 6.3 | 4.04 | 1.14 | 0.53 | 0.28 | Upgrade
|
| EBIT | -38.26 | -31.59 | -21.92 | -21.37 | -16.76 | -19.78 | Upgrade
|
| EBIT Margin | -143.14% | -125.43% | -115.81% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.